RETREG1 and hepatocellular carcinoma: circFAM134B as a regulator of ER-phagy-mediated ferroptosis in hepatocellular carcinoma (HCC) by sponging PABPC4 to stabilize FAM134B mRNA, enhancing the effectiveness of lenvatinib treatment through increased ROS and Fe2+ levels.